THE ACTIONS OF EXOGENOUS DEHYDROEPIANDROSTERONE IN EXPERIMENTAL-ANIMALS AND HUMANS

Authors
Citation
F. Svec et Jr. Porter, THE ACTIONS OF EXOGENOUS DEHYDROEPIANDROSTERONE IN EXPERIMENTAL-ANIMALS AND HUMANS, Proceedings of the Society for Experimental Biology and Medicine, 218(3), 1998, pp. 174-191
Citations number
137
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
00379727
Volume
218
Issue
3
Year of publication
1998
Pages
174 - 191
Database
ISI
SICI code
0037-9727(1998)218:3<174:TAOEDI>2.0.ZU;2-D
Abstract
Dehydroepiandrosterone (DHEA) is the major adrenal steroid of young ad ults; however, its physiologic functions, if any, are not known. The p urpose of this review is to evaluate the current literature in which D HEA was administered to either humans or experimental animals to disce rn what these functions might be. Reports are divided into five areas: neurologic, immunologic, cardiovascular, oncologic, and metabolic. Pa rticular attention is paid to the dosage and route of administration. This type of analysis shows that at the lowest doses, DHEA has effects on neurologic and immunologic tissues, suggesting that these two site s may be physiologic targets. DHEA also affects cardiologic and metabo lic functions as well as tumor growth, but such actions require higher doses and may reflect 'pharmacologic' activities. It is proposed that DHEA's pattern of activity represents a new class of steroid hormones , the ''Regnantoids.'' Further progress in the endocrinology of this f amily of steroids may only come when synthetic, long-acting analogs of DHEA are available for in vitro studies to allow correlations between hormone action and receptor binding.